National Securities Downgrades Recro Pharma (REPH) to Sell
Tweet Send to a Friend
National Securities downgraded Recro Pharma (NASDAQ: REPH) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
